|
There's Now a $1-a-Pill Competitor to Pharma CEO Martin Shkreli's $750-a-Pill DrugBusiness InsiderOct. 23, 2015 |
Popular 
Report: Blinken Sitting On Staff Recommendations to Sanction Israeli Military Units Linked to Killings or Rapes
America Last: House Bill Provides $26B for Israel, $61B for Ukraine and Zero to Secure U.S. Border
Bari Weiss' Free Speech Martyr Uri Berliner Wants FBI and Police to Spy on Pro-Palestine Activists
John Hagee Cheers Israel-Iran Battle as 'Gog and Magog War,' Will Lobby Congress Not to Deescalate
'Woke' Google Fires 28 Employees Who Protested Gaza Genocide
 Almost a month after word got out that drug-company CEO Martin Shkreli had jacked up the price of a critical drug by more than 5,000%, a different kind of pharma company has stepped up to provide a cheaper alternative. Read More 
|
